The former chief financial officer of The Epoch Times Association, Inc., Weidong Guan, has pleaded guilty in the Southern District of New York to participating in a conspiracy involving at least $67 million in illicit funds. The case is notable not only for the size of the alleged laundering operation, but also because it involves a senior finance executive at a media organization and is being prosecuted in one of the country’s most prominent white-collar enforcement venues.

For legal professionals, the plea is a reminder of how aggressively federal prosecutors continue to pursue anti-money-laundering cases tied to corporate insiders.

The Justice Department announced June 30 that a Honduras-based Chinese national extradited from Guatemala has pleaded guilty in the United States to narcotics trafficking conspiracy, money laundering conspiracy, and providing material support to the Cartel de Jalisco Nueva Generación, or CJNG. The plea stands out because it brings together several enforcement themes that are increasingly important in federal criminal practice: transnational narcotics distribution, cartel-related financial networks, material-support allegations, and cross-border extradition.

Although the matter may not draw the same immediate attention as a Supreme Court opinion or a blockbuster antitrust suit, it is significant for lawyers tracking how the government is framing cartel prosecutions.

A Mexican national has pleaded guilty in a federal case alleging participation in a two-year, multimillion-dollar trade-based money-laundering conspiracy that moved drug proceeds from Texas to Mexico. The prosecution is notable not just for the plea itself, but for what it says about current federal enforcement priorities: the Justice Department continues to target the financial infrastructure that supports narcotics trafficking, not only the traffickers who generate the proceeds.

According to the government, the scheme involved a black-market peso exchange structure, a long-running money-laundering method used to convert U.S. drug cash into usable funds in Mexico through cross-border trade transactions.